PTK2 and breast cancer: LRRN1 overexpression consistently downregulated the protein expression of focal adhesion kinase (FAK), matrix metalloproteinase-2 (MMP2), and matrix metalloproteinase-9 (MMP9) in both breast cancer cellines (Figures 4K-N).